Eli Lilly attempts to block Sun Pharma's generic Strattera

09/25/2007 | Business Standard (India)

Eli Lilly & Co. has filed a patent infringement suit against Sun Pharmaceutical Industries, which seeks to produce and sell a generic version of Lilly's attention deficit hyperactivity disorder drug Strattera. In a complaint filed Sept. 20, Eli Lilly said the company would be "irreparably harmed" by the FDA's approval of Sun's request.

View Full Article in:

Business Standard (India)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ